| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 研发项目(元) | 636,852,225.00 | 1,894,758,860.00 | 1,386,877,475.00 | 1,548,237,291.00 | 1,043,182,061.00 |
| 医药制造业(元) | 8,143,921,768.00 | 19,212,005,407.00 | 10,076,290,386.00 | 19,166,056,039.00 | 9,323,763,721.00 |
| 其他(元) | - | - | - | - | 366,980,827.00 |
| 营业成本(元) | |||||
| 研发项目(元) | 273,144,978.00 | 653,752,620.00 | 304,183,878.00 | 748,819,711.00 | 337,202,865.00 |
| 医药制造业(元) | 4,043,319,361.00 | 9,328,389,088.00 | 4,882,210,440.00 | 8,921,457,077.00 | 4,384,958,039.00 |
| 其他(元) | - | - | - | - | 292,842,502.00 |
| 毛利(元) | |||||
| 研发项目(元) | 363,707,247.00 | 1,241,006,240.00 | 1,082,693,597.00 | 799,417,580.00 | 705,979,196.00 |
| 医药制造业(元) | 4,100,602,407.00 | 9,883,616,319.00 | 5,194,079,946.00 | 10,244,598,962.00 | 4,938,805,682.00 |
| 其他(元) | - | - | - | - | 74,138,325.00 |
| 毛利率(%) | |||||
| 研发项目(%) | 57.11 | 65.50 | 78.07 | 51.63 | 67.68 |
| 医药制造业(%) | 50.35 | 51.45 | 51.55 | 53.45 | 52.97 |
| 其他(%) | - | - | - | - | 20.20 |
| 收入构成(%) | |||||
| 研发项目(%) | 7.25 | 8.98 | 12.10 | 7.47 | 9.72 |
| 医药制造业(%) | 92.75 | 91.02 | 87.90 | 92.53 | 86.86 |
| 其他(%) | - | - | - | - | 3.42 |
| 毛利构成(%) | |||||
| 研发项目(%) | 8.15 | 11.16 | 17.25 | 7.24 | 12.34 |
| 医药制造业(%) | 91.85 | 88.84 | 82.75 | 92.76 | 86.36 |
| 其他(%) | - | - | - | - | 1.30 |